These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 26964658)

  • 21. [Behavioral and neurochemical study on the role of the brain cholecystokinin system in anxiety].
    Izumi T
    Hokkaido Igaku Zasshi; 1998 Sep; 73(5):463-73. PubMed ID: 9846276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Idiopathic environmental intolerance: increased prevalence of panic disorder-associated cholecystokinin B receptor allele 7.
    Binkley K; King N; Poonai N; Seeman P; Ulpian C; Kennedy J
    J Allergy Clin Immunol; 2001 May; 107(5):887-90. PubMed ID: 11344357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray.
    Netto CF; Guimarães FS
    Neuropsychopharmacology; 2004 Jan; 29(1):101-7. PubMed ID: 14583742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pentagastrin test for anxiety--psychophysiology and personality.
    Radu D; Ahlin A; Svanborg P; Lindefors N
    Psychopharmacology (Berl); 2003 Mar; 166(2):139-45. PubMed ID: 12529809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding sites and transduction process of the cholecystokininB receptor: involvement of highly conserved aromatic residues of the transmembrane domains evidenced by site-directed mutagenesis.
    Jagerschmidt A; Guillaume N; Roques BP; Noble F
    Mol Pharmacol; 1998 May; 53(5):878-85. PubMed ID: 9584214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neuropharmacological and genetic study of panic disorder].
    Akiyoshi J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Jul; 19(3):93-9. PubMed ID: 10495983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [From inducers of panic attack to neurobiology of panic disorder].
    Bourin M
    Encephale; 1996 Dec; 22 Spec No 5():35-41. PubMed ID: 9138945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCKB receptors mediate CCK-8S-induced activation of dorsal hippocampus CA3 pyramidal neurons: an in vivo electrophysiological study in the rat.
    Gronier B; Debonnel G
    Synapse; 1995 Oct; 21(2):158-68. PubMed ID: 8584977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholecystokinin and endogenous opioid peptides: interactive influence on pain, cognition, and emotion.
    Hebb AL; Poulin JF; Roach SP; Zacharko RM; Drolet G
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Dec; 29(8):1225-38. PubMed ID: 16242828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Missense mutation of the cholecystokinin B receptor gene: lack of association with panic disorder.
    Kato T; Wang ZW; Zoega T; Crowe RR
    Am J Med Genet; 1996 Jul; 67(4):401-5. PubMed ID: 8837709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic stimulation of corticotropin-releasing factor receptor 1 enhances the anxiogenic response of the cholecystokinin system.
    Sherrin T; Todorovic C; Zeyda T; Tan CH; Wong PT; Zhu YZ; Spiess J
    Mol Psychiatry; 2009 Mar; 14(3):291-307. PubMed ID: 18195718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study.
    Zwanzger P; Eser D; Aicher S; Schüle C; Baghai TC; Padberg F; Ella R; Möller HJ; Rupprecht R
    Neuropsychopharmacology; 2003 May; 28(5):979-84. PubMed ID: 12700707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioral and cortical EEG evaluations confirm the roles of both CCKA and CCKB receptors in mouse CCK-induced anxiety.
    Li H; Ohta H; Izumi H; Matsuda Y; Seki M; Toda T; Akiyama M; Matsushima Y; Goto Y; Kaga M; Inagaki M
    Behav Brain Res; 2013 Jan; 237():325-32. PubMed ID: 23043971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular effects of cholecystokinin-4 are mediated by the cholecystokinin-B receptor subtype in the conscious guinea pig and dog.
    Fossa AA; DePasquale MJ; Morrone J; Zorn SH; Bryce D; Lowe JA; McLean S
    J Pharmacol Exp Ther; 1997 Apr; 281(1):180-7. PubMed ID: 9103496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central cholecystokinin activity in irritable bowel syndrome, panic disorder, and healthy controls.
    Koszycki D; Torres S; Swain JE; Bradwejn J
    Psychosom Med; 2005; 67(4):590-5. PubMed ID: 16046372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ventilatory response to cholecystokinin tetrapeptide in healthy volunteers.
    Katzman MA; Duffin J; Shlik J; Bradwejn J
    Neuropsychopharmacology; 2002 Jun; 26(6):824-31. PubMed ID: 12007753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats.
    Bertoglio LJ; Zangrossi H
    Brain Res; 2005 Oct; 1059(1):46-51. PubMed ID: 16168394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI.
    Schunck T; Mathis A; Erb G; Namer IJ; Hode Y; Demazières A; Luthringer R
    J Psychopharmacol; 2011 Jan; 25(1):52-9. PubMed ID: 20498136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague-Dawley rats using elevated plus-maze test apparatus.
    Farook JM; Zhu YZ; Wang Q; Moochhala SM; Lee L; Wong PT
    Neurosci Lett; 2004 Apr; 358(3):215-9. PubMed ID: 15039119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.